Mesoporous silica nanoparticles as drug delivery system

Journal of Nanomedicine and Nanotechnology

Volumn 2, Issue 3, 2011, Pages

  Douroumis, Dennis ^a  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857004936     PISSN: None     EISSN: 21577439     Source Type: Journal    
DOI: 10.4172/2157-7439.1000102e     Document Type: Editorial

References (6)

1. Lu J, Liong M, Zink JI, Tamanoi F (2007) Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 3: 1341-6.
2. He Q, Shi J, Chen F, Zhu M, Zhang L (2008) An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. Biomaterials 2010 31:3335-3346.
3. Hudson SP, Padera RF, Langer R, Kohane DS (2008) The biocompatibility of mesoporous silicates. Biomaterials. 29: 4045-55.
4. Lu J, Liong M, Li Z, Zink JI, Tamanoi F (2010) Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 6: 1794-1805.
5. He Q, Zhang Z, Gao F, Li Y, Shi J (2011) In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small 7: 271-280.
6. Li L, Tang F, Liu H, Liu T, Hao N, et al. (2010) In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. ACS Nano 4: 6874-6882.